Nadir Hastalıklarda Avrupa Ortak Programı 2022 Yılı Çağrısı’na Katılımı Artırmaya Yönelik Genişleme Sürecine 29 Mayıs 2022 tarihine kadar başvurabilirsiniz.
  26 May 2022

The First stage of European Joint Programme on Rare Diseases (EJP RD) JTC2022 Call “Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases “ has been finalized.

In order to increase participation from underrepresented countries, the "widening" process will be operated under the EJP RD JTC2022 call. The widening process will involve the inclusion of eligible partners from countries wishing to participate in project consortia moving into the second phase. Accordingly, relevant researchers from Turkey will be able to be included in the project consortia that have passed to the second stage.

Researchers who want to participate in the widening process must carry out research activities in areas suitable for the call title, meet the conditions of the international call and the provisions of the TÜBİTAK 1071- Support Program for Increasing the Capacity to Benefit from International Research Funds and Participation in International R&D Collaborations.

Researchers who would like to participate in the widening process must contact to EJP RD National Coordinator, Dr. Jale ŞAHİN by sending an e-mail to jale.sahin@tubitak.gov.tr until  29 May 2022.

Similar News